Advanced Nutriceuticals, LLC Recalls

FDA
17
Total Recalls
1
Agencies
Dec 2020
First Recall
Dec 2020
Latest Recall

Showing 1-17 of 17 recalls

FDA

B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

DSIP, 1000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

AOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

CJC-1295, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

NANDROLONE, 200 MCG/ML, 2 ML, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

Pentosan Polysulfate, 300 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

FDA

GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN